| Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes R Cristescu, J Lee, M Nebozhyn, KM Kim, JC Ting, SS Wong, J Liu, ... Nature medicine 21 (5), 449-456, 2015 | 1865 | 2015 |
| Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy R Cristescu, R Mogg, M Ayers, A Albright, E Murphy, J Yearley, X Sher, ... Science 362 (6411), eaar3593, 2018 | 1851 | 2018 |
| Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer ST Kim, R Cristescu, AJ Bass, KM Kim, JI Odegaard, K Kim, XQ Liu, ... Nature medicine 24 (9), 1449-1458, 2018 | 1271 | 2018 |
| T-cell–inflamed gene-expression profile, programmed death ligand 1 expression, and tumor mutational burden predict efficacy in patients treated with pembrolizumab across 20 … PA Ott, YJ Bang, SA Piha-Paul, ARA Razak, J Bennouna, JC Soria, ... Journal of Clinical Oncology 37 (4), 318-327, 2019 | 764 | 2019 |
| On network correlated data gathering R Cristescu, B Beferull-Lozano, M Vetterli IEEE INFOCOM 2004 4, 2571-2582, 2004 | 466 | 2004 |
| An unbiased oncology compound screen to identify novel combination strategies J O'Neil, Y Benita, I Feldman, M Chenard, B Roberts, Y Liu, J Li, A Kral, ... Molecular cancer therapeutics 15 (6), 1155-1162, 2016 | 272 | 2016 |
| Pembrolizumab for patients with refractory or relapsed thymic epithelial tumor: an open-label phase II trial J Cho, HS Kim, BM Ku, YL Choi, R Cristescu, J Han, JM Sun, SH Lee, ... J clin oncol 37 (24), 2162-70, 2019 | 266 | 2019 |
| Network correlated data gathering with explicit communication: NP-completeness and algorithms R Cristescu, B Beferull-Lozano, M Vetterli, R Wattenhofer IEEE/ACM Transactions On Networking 14 (1), 41-54, 2006 | 223 | 2006 |
| Power-efficient sensor placement and transmission structure for data gathering under distortion constraints D Ganesan, R Cristescu, B Beferull-Lozano ACM Transactions on Sensor Networks (TOSN) 2 (2), 155-181, 2006 | 215 | 2006 |
| Networked Slepian-Wolf: theory, algorithms, and scaling laws R Cristescu, B Beferull-Lozano, M Vetterli IEEE Transactions on Information Theory 51 (12), 4057-4073, 2005 | 212 | 2005 |
| Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination S Fourati, R Cristescu, A Loboda, A Talla, A Filali, R Railkar, AK Schaeffer, ... Nature communications 7 (1), 10369, 2016 | 172 | 2016 |
| Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing SS Wong, KM Kim, JC Ting, K Yu, J Fu, S Liu, R Cristescu, M Nebozhyn, ... Nature communications 5 (1), 5477, 2014 | 172 | 2014 |
| Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice F Veglia, A Hashimoto, H Dweep, E Sanseviero, A De Leo, E Tcyganov, ... Journal of Experimental Medicine 218 (4), 2021 | 165 | 2021 |
| Association between tissue TMB (tTMB) and clinical outcomes with pembrolizumab monotherapy (pembro) in PD-L1-positive advanced NSCLC in the KEYNOTE-010 and-042 trials RS Herbst, G Lopes, DM Kowalski, M Nishio, YL Wu, G de Castro Junior, ... Annals of Oncology 30, v916-v917, 2019 | 107 | 2019 |
| Pembrolizumab (pembro) plus platinum-based chemotherapy (chemo) for metastatic NSCLC: tissue TMB (tTMB) and outcomes in KEYNOTE-021, 189, and 407 L Paz-Ares, CJ Langer, S Novello, B Halmos, Y Cheng, SM Gadgeel, ... Annals of Oncology 30, v917-v918, 2019 | 99 | 2019 |
| Tumor mutational burden predicts the efficacy of pembrolizumab monotherapy: a pan-tumor retrospective analysis of participants with advanced solid tumors R Cristescu, D Aurora-Garg, A Albright, L Xu, XQ Liu, A Loboda, L Lang, ... Journal for immunotherapy of cancer 10 (1), 2022 | 96 | 2022 |
| LBA4 Association of KRAS mutational status with response to pembrolizumab monotherapy given as first-line therapy for PD-L1-positive advanced non-squamous NSCLC in Keynote-042 RS Herbst, G Lopes, DM Kowalski, K Kasahara, YL Wu, G De Castro Jr, ... Annals of Oncology 30, xi63-xi64, 2019 | 96 | 2019 |
| High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features X Liu, MG Choi, K Kim, KM Kim, ST Kim, SH Park, R Cristescu, S Peter, ... Pathology-Research and Practice 216 (4), 152881, 2020 | 94 | 2020 |
| OA04. 06 evaluation of TMB in KEYNOTE-189: pembrolizumab plus chemotherapy vs placebo plus chemotherapy for nonsquamous NSCLC M Garassino, D Rodriguez-Abreu, S Gadgeel, E Esteban, E Felip, ... Journal of Thoracic Oncology 14 (10), S216-S217, 2019 | 93 | 2019 |
| On the optimal density for real-time data gathering of spatio-temporal processes in sensor networks R Cristescu, M Vetterli IPSN 2005. Fourth International Symposium on Information Processing in …, 2005 | 87 | 2005 |
